Financial reports
ARS
2023 FY
Annual report to shareholders
9 Apr 24
10-K
2023 FY
Annual report
20 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
14 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Other Events
5 Jan 24
8-K
Multiple Clinical and Preclinical Presentations at ASH 2023
2 Nov 23
8-K
Regulation FD Disclosure
9 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
8-K
Departure of Directors or Certain Officers
14 Apr 23
8-K
Regulation FD Disclosure
16 Feb 23
8-K
Entry into a Material Definitive Agreement
23 Dec 22
8-K
Termination of a Material Definitive Agreement
14 Dec 22
8-K
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent
7 Dec 22
8-K
Regulation FD Disclosure
7 Dec 22
Registration and prospectus
S-8
Registration of securities for employees
20 Mar 24
S-8
Registration of securities for employees
30 Aug 23
S-8
Registration of securities for employees
23 Mar 23
424B5
Prospectus supplement for primary offering
23 Dec 22
S-3
Shelf registration
14 Dec 22
424B5
Prospectus supplement for primary offering
8 Dec 22
S-3
Shelf registration
14 Mar 22
S-8
Registration of securities for employees
14 Mar 22
S-8
Registration of securities for employees
9 Feb 21
424B4
Prospectus supplement with pricing info
8 Feb 21
Other
EFFECT
Notice of effectiveness
21 Dec 22
CORRESP
Correspondence with SEC
16 Dec 22
UPLOAD
Letter from SEC
15 Dec 22
EFFECT
Notice of effectiveness
21 Mar 22
CORRESP
Correspondence with SEC
16 Mar 22
UPLOAD
Letter from SEC
16 Mar 22
EFFECT
Notice of effectiveness
5 Feb 21
SEC STAFF
SEC staff action: Order
4 Feb 21
CERT
Certification of approval for exchange listing
3 Feb 21
CORRESP
Correspondence with SEC
2 Feb 21
Ownership
4
Nathan D. Jorgensen
5 Mar 24
4
Tirtha Chakraborty
5 Mar 24
4
ROBERT ANG
5 Mar 24
SC 13D/A
5AM Ventures VI, L.P.
14 Feb 24
SC 13G/A
Paradigm Biocapital Advisors LP
14 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Eyal C. Attar
8 Feb 24
4
ROBERT ANG
8 Feb 24
4
Nathan D. Jorgensen
8 Feb 24
4
Tirtha Chakraborty
8 Feb 24